BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 19578865)

  • 21. Immunomodulatory activity of a plant extract containing human papillomavirus 16-E7 protein in human monocyte-derived dendritic cells.
    Di Bonito P; Grasso F; Mangino G; Massa S; Illiano E; Franconi R; Fanales-Belasio E; Falchi M; Affabris E; Giorgi C
    Int J Immunopathol Pharmacol; 2009; 22(4):967-78. PubMed ID: 20074460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disease-stage variance in functional CD4(+) T-cell responses against novel pan-human leukocyte antigen-D region presented human papillomavirus-16 E7 epitopes.
    Warrino DE; Olson WC; Knapp WT; Scarrow MI; D'Ambrosio-Brennan LJ; Guido RS; Edwards RP; Kast WM; Storkus WJ
    Clin Cancer Res; 2004 May; 10(10):3301-8. PubMed ID: 15161683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12.
    Zou W; Borvak J; Marches F; Wei S; Galanaud P; Emilie D; Curiel TJ
    J Immunol; 2000 Oct; 165(8):4388-96. PubMed ID: 11035076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CpG-ODN-stimulated dendritic cells act as a potent adjuvant for E7 protein delivery to induce antigen-specific antitumour immunity in a HPV 16 E7-associated animal tumour model.
    Kim TG; Kim CH; Won EH; Bae SM; Ahn WS; Park JB; Sin JI
    Immunology; 2004 May; 112(1):117-25. PubMed ID: 15096191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of DNA- and mRNA-transfected mouse dendritic cells as potential vaccines against the human papillomavirus type 16 associated oncoprotein E7.
    Dell K; Klein C; Gissmann L
    Antivir Ther; 2008; 13(4):495-509. PubMed ID: 18672528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxic T-lymphocyte responses to human papillomavirus type 16 E5 and E7 proteins and HLA-A*0201-restricted T-cell peptides in cervical cancer patients.
    Liu DW; Yang YC; Lin HF; Lin MF; Cheng YW; Chu CC; Tsao YP; Chen SL
    J Virol; 2007 Mar; 81(6):2869-79. PubMed ID: 17202211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression.
    Radford KJ; Turtle CJ; Kassianos AJ; Hart DN
    J Immunother; 2006; 29(6):596-605. PubMed ID: 17063122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential indirect activation of human invariant natural killer T cells by Toll-like receptor agonists.
    Moreno M; Mol BM; von Mensdorff-Pouilly S; Verheijen RH; de Jong EC; von Blomberg BM; van den Eertwegh AJ; Scheper RJ; Bontkes HJ
    Immunotherapy; 2009 Jul; 1(4):557-70. PubMed ID: 20635987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of an HLA-A24-restricted cytotoxic T lymphocyte epitope from human papillomavirus type-16 E6: the combined effects of bortezomib and interferon-gamma on the presentation of a cryptic epitope.
    Morishima S; Akatsuka Y; Nawa A; Kondo E; Kiyono T; Torikai H; Nakanishi T; Ito Y; Tsujimura K; Iwata K; Ito K; Kodera Y; Morishima Y; Kuzushima K; Takahashi T
    Int J Cancer; 2007 Feb; 120(3):594-604. PubMed ID: 17096336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
    Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
    Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide.
    Jochmus I; Osen W; Altmann A; Buck G; Hofmann B; Schneider A; Gissmann L; Rammensee HG
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1689-95. PubMed ID: 9225046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens.
    Arribillaga L; Echeverria I; Belsue V; Gomez T; Lozano T; Casares N; Villanueva L; Domingos-Pereira S; Romero PJ; Nardelli-Haefliger D; Hervás-Stubbs S; Sarobe P; Rodriguez MJ; Carrascosa JL; Zürcher T; Lasarte JJ
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human CD8⁺ T cells drive Th1 responses through the differentiation of TNF/iNOS-producing dendritic cells.
    Chong SZ; Wong KL; Lin G; Yang CM; Wong SC; Angeli V; Macary PA; Kemeny DM
    Eur J Immunol; 2011 Jun; 41(6):1639-51. PubMed ID: 21469104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential activation of dendritic cells by toll-like receptors causes diverse differentiation of naïve CD4+ T cells from allergic patients.
    Deifl S; Kitzmüller C; Steinberger P; Himly M; Jahn-Schmid B; Fischer GF; Zlabinger GJ; Bohle B
    Allergy; 2014 Dec; 69(12):1602-9. PubMed ID: 25093709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
    Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
    J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the immunopotency of Toll-like receptor agonists in an in vitro tissue-engineered immunological model.
    Ma Y; Poisson L; Sanchez-Schmitz G; Pawar S; Qu C; Randolph GJ; Warren WL; Mishkin EM; Higbee RG
    Immunology; 2010 Jul; 130(3):374-87. PubMed ID: 20331478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro generation and life span extension of human papillomavirus type 16-specific, healthy donor-derived CTL clones.
    Schreurs MW; Scholten KB; Kueter EW; Ruizendaal JJ; Meijer CJ; Hooijberg E
    J Immunol; 2003 Sep; 171(6):2912-21. PubMed ID: 12960314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dendritic cells present particulate E7 protein of human papillomavirus and induce strong immunity].
    Li J; Gao HQ; Zhao CL; Li LZ; Ji CY; Hou M; Plebaski M
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):932-6. PubMed ID: 15329282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations.
    Cheng WF; Lee CN; Su YN; Chang MC; Hsiao WC; Chen CA; Hsieh CY
    Immunology; 2005 May; 115(1):136-49. PubMed ID: 15819706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 17β-Estradiol influences in vitro response of aged rat splenic conventional dendritic cells to TLR4 and TLR7/8 agonists in an agonist specific manner.
    Stojić-Vukanić Z; Nacka-Aleksić M; Bufan B; Pilipović I; Arsenović-Ranin N; Djikić J; Kosec D; Leposavić G
    Int Immunopharmacol; 2015 Jan; 24(1):24-35. PubMed ID: 25479725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.